Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,257,685
-$73,266,123 QoQ
Shares Held
481,833
-73.0% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
#63
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Derivatives in GSK
reported options exposure · as of Dec 31, 2022CallValue
$73,572,618
CallShares
2,093,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Eversept Partners, LP holds $59,814,180 across 4 Drug Manufacturers - General names. GSK ranks #1 (42.2% of the industry book) .
All Filings in GSK
Export CSV
35 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,257,685 | 481,833 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $98,523,808 | 1,785,175 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $131,413,517 | 2,679,721 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $91,518,449 | 2,120,446 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $86,107,699 | 2,242,388 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $101,624,550 | 2,623,246 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $123,840,993 | 3,661,768 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $165,858,581 | 4,057,206 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $133,521,080 | 3,468,080 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $161,705,382 | 3,771,994 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $110,177,675 | 2,972,954 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $118,151,147 | 3,259,342 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $102,679,267 | 2,881,012 | Shares | Sole | 2023-11-08 | |
| 2023-03-31 | $132,766,734 | 3,731,499 | Shares | Sole | 2023-11-08 | |
| 2022-12-31 | $122,654,658 | 3,490,457 | Shares | Sole | 2023-11-08 | |
| 2022-12-31 | $73,572,618 | 2,093,700 | Call | Sole | 2023-11-08 | |
| 2022-09-30 | $61,617,591 | 2,093,700 | Call | Sole | 2023-11-08 | |
| 2022-09-30 | $86,496,830 | 2,939,070 | Shares | Sole | 2023-11-08 | |
| 2022-06-30 | $68,059,759 | 1,594,121 | Shares | Sole | 2023-11-08 | |
| 2022-06-30 | $66,334,015 | 1,553,700 | Call | Sole | 2023-11-08 | |
| 2022-03-31 | $66,379,731 | 1,553,700 | Call | Sole | 2023-11-08 | |
| 2022-03-31 | $53,795,994 | 1,259,162 | Shares | Sole | 2023-11-08 | |
| 2021-12-31 | $24,533,476 | 567,205 | Shares | Sole | 2023-11-08 | |
| 2021-12-31 | $65,039,957 | 1,503,700 | Call | Sole | 2023-11-08 | |
| 2021-09-30 | $15,052,533 | 401,654 | Shares | Sole | 2023-11-08 | |
| 2021-09-30 | $56,353,214 | 1,503,700 | Call | Sole | 2023-11-08 | |
| 2021-06-30 | $4,400,729 | 112,679 | Shares | Sole | 2023-11-08 | |
| 2021-06-30 | $54,822,143 | 1,403,700 | Call | Sole | 2023-11-08 | |
| 2021-03-31 | $40,398,984 | 1,154,100 | Call | Sole | 2023-11-08 | |
| 2021-03-31 | $29,831,259 | 852,206 | Shares | Sole | 2023-11-08 | |
| 2020-12-31 | $12,726,546 | 352,600 | Call | Sole | 2023-11-08 | |
| 2020-12-31 | $34,165,364 | 946,581 | Shares | Sole | 2023-11-08 | |
| 2020-09-30 | $2,376,441 | 64,372 | Shares | Sole | 2023-11-08 | |
| 2020-06-30 | $9,092,072 | 227,263 | Shares | Sole | 2023-11-08 | |
| 2020-03-31 | $18,974,100 | 510,571 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||